PDX-001

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePDX-001
Drug Alias NamePDX-001PDX-001-TX
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPdx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPdx Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A